diphenyleneiodonium has been researched along with rifampin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karmodiya, K; Mishra, S; Ramya, TN; Surolia, A; Surolia, N | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Chopra, S; Dasgupta, A; Karaulia, P; Pandey, AK; Pandey, M; Singh, AK; Talwar, S; Thakare, R | 1 |
3 other study(ies) available for diphenyleneiodonium and rifampin
Article | Year |
---|---|
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
Topics: Acetone; Animals; Antimalarials; Azithromycin; Cerulenin; Chloramphenicol; Clindamycin; Erythrocytes; Fatty Acids; Gene Dosage; Humans; Organelles; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Tetracycline; Thioctic Acid; Triclosan | 2007 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Repositioning; Drug Synergism; Enzyme Inhibitors; Mice; Microbial Viability; Mycobacterium tuberculosis; NADH, NADPH Oxidoreductases; Onium Compounds; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Tuberculosis | 2017 |